SCIVAX and Shin-Etsu Chemical Have Jointly Developed Amtelus ® , the World’s Smallest Light Source Device for 3D Sensors
31.10.2024 08:59:00 CET | Business Wire | Press Release
SCIVAX Corporation (Head Office: Kawasaki, Japan; President: Satoru Tanaka; hereinafter, “SCIVAX”) and Shin-Etsu Chemical Co., Ltd. (Head Office: Tokyo; President: Yasuhiko Saitoh; hereinafter, “Shin-Etsu Chemical”) have jointly developed Amtelus®, a light source device for 3D sensors and technology for its mass-production. The delivery of evaluation samples of Amtelus® will start in November 2024, and the sales of the products will be conducted by Shin-Etsu Chemical.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030531343/en/
World’s smallest light source module Amtelus® (Photo: Business Wire)
SCIVAX has so far sold Platanus®, an optical lens that diffuses and radiates light uniformly, as the 3D sensor light sources that are used in automotive and other various applications, contributing to improving sensor performance. Meanwhile, in recent years, the areas in which 3D sensing technology is utilized have grown wider, calling for light source devices to be more highly integrated and to have higher performance. However, it was difficult to reduce footprint using the conventional cavity structure, which posed one of the major unsolved issues.
To solve this issue, Shin-Etsu Chemical has developed a high-hardness material that can be processed by dicing, and that has both necessary optical properties and a sealing capability to protect devices. Using this material, SCIVAX has successfully developed Amtelus®, the world’s smallest light source device that incorporates the functions of Platanus®. This device has achieved a significantly smaller size compared with conventional devices having a mounting area of 1 mm2 or less, 10 times smaller than conventional devices, and with half or less of the thickness.
The main features of Amtelus® are as follows:
- Minimum size
It minimizes the mounting area of a light-emitting device, enabling its application in devices such as AR glasses and smartphones, for which installation has been difficult. In addition, using multiple Amtelus® modules can achieve more precise sensing. - Flexibility of light emission
The optical lens Platanus® can provide various types of irradiation fields with a high degree of design flexibility, enabling various types of irradiation, such as over a wide range of 140 degrees or more or with a high aspect ratio (120 deg × 30 deg). By using this technology, Amtelus® modules with various irradiation fields can be designed according to customers’ requests. - Cost competitiveness
By utilizing advanced nanoimprint mass production technology, the lenses are integrated with the light source in a resin package, which provides higher cost competitiveness compared to conventional products.
Shin-Etsu Chemical and SCIVAX are considering expanding the applications of this technology in the future to various fields, such as next-generation life science, mainly vital sensors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030531343/en/
Contacts
For inquiries about this matter, please contact:
SCIVAX Corporation
Optical device business Div.
Koichi Aida
Tel: +81-44-599-5051
https://www.scivax.com/en/inquiry/ -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.scivax.com
%2Fen%2Finquiry%2F&esheet=54145246&newsitemid=20241030531343&lan=en-US&anchor=ht
tps%3A%2F%2Fwww.scivax.com%2Fen%2Finquiry%2F&index=2&md5=48757c993876c6eb03fa2c2
8fb59b362
Shin-Etsu Chemical Co., Ltd.
Public Relations Dept.
Tetsuya Koishikawa
Tel: +81-3-6812-2340
https://www.shinetsu.co.jp/jp/inquiry/?d=shinetsu&t=shinetsu -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.shinetsu.c
o.jp%2Fjp%2Finquiry%2F%3Fd%3Dshinetsu%26t%3Dshinetsu&esheet=54145246&newsitemid=
20241030531343&lan=en-US&anchor=https%3A%2F%2Fwww.shinetsu.co.jp%2Fjp%2Finquiry%
2F%3Fd%3Dshinetsu%26amp%3Bt%3Dshinetsu&index=3&md5=dcd0e5fe6573b41921a1150c5a1a9
419
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PMC Organometallix Announces Price Increase on All Products24.4.2026 23:02:00 CEST | Press Release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press Release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 16:37:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan
Banma Intelligence and Alipay Launch AI Cockpit Solution Powered by Alipay AI Pay, Enabling Seamless and Secure In-Car Transactions by Voice24.4.2026 16:04:00 CEST | Press Release
At the 2026 Beijing International Automotive Exhibition (“Auto China 2026”), OS and AI technology company Banma Intelligence and Alipay today launched a new AI cockpit solution integrating Alipay AI Pay, enabling drivers to complete purchases by voice command directly from their vehicle. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424618328/en/ Industry-first AI Cockpit Solution with Alipay AI Pay Unveiled “In the past two years, smart cockpits have achieved rapid advances in perception and decision-making,” said Ming Cai, Banma Intelligence Chief Product Officer. “With large models onboard, vehicles can understand user intent and make recommendations. By integrating Alipay AI Pay into our AI cockpit solution, we are removing the last friction point in the in-car smart cockpit experience - drivers simply speak to pay, no phone required.” The new AI cockpit solution initially covers two high-frequency use cases: enterta
Spatial Announces the Release 2026 1.0.1: New Enhancements Across 3D InterOp, Data Prep, Meshing, and 3D Modeling SDKs24.4.2026 15:21:00 CEST | Press Release
Spatial Corp., the leading software development kit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, today announced new enhancements across several of its product lines. These updates further strengthen Spatial’s commitment to delivering high-performance solutions that optimize interoperability, data preparation, and advanced modeling workflows. Designed to improve efficiency and robustness across CAD translation, modeling, meshing, and simulation processes, the latest updates introduce expanded format support, enhanced PMI handling, and new capabilities for complex geometry processing. 3D InterOp NX Reader Enhancement for 2D Drawings The NX reader imports 2D drawings as visualization data from NX 2412 and later versions. glTF Writer Supports Draco Compression glTF export incorporates Draco compression for meshes and point-clouds to significantly reduce output file sizes. Enhanced Support for Reading Product Manufacturing Information
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom